Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation

Journal of Virology

Volumn 88, Issue 9, 2014, Pages 5189-5194

  Fukuda, Makoto ^a,b   Kawaguchi, Yasushi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; PROTEIN KINASE B; PROTEIN KINASE SYK; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ANCHORAGE; CELL GROWTH; CELL STRAIN HEK293; CELL STRAIN MCF 7; CELL SURVIVAL; CELL TRANSFORMATION; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

CELL LINE; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF; MUTANT PROTEINS; VIRAL MATRIX PROTEINS;

EID: 84897536464     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03714-13     Document Type: Article

References (39)

1. Rickinson AB, Kieff E. 2007. Epstein-Barr virus, p 2655-2700. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott, Williams and Wilkins, Philadelphia, PA.
2. Longnecker R. 2000. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv. Cancer Res. 79:175-200. http://dx.doi.org/10.1016/S0065-230X(00)79006-3.
3. Thorley-Lawson DA, Gross A. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350:1328-1337. http://dx.doi.org/10.1056/NEJMra032015.
4. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768. http://dx.doi.org/10.1038/nrc1452.
5. Lynch DT, Zimmerman JS, Rowe DT. 2002. Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. J. Gen. Virol. 83:1025-1035. http://vir.sgmjournals.org/content/83/5/1025.long.
6. Ikeda M, Fukuda M, Longnecker R. 2005. Function of latent membrane protein 2A, p 531-550. In Robertson E (ed), Epstein-Barr virus. Caister Academic Press, Wymondham, England.
7. Fruehling S, Longnecker R. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241-251. http://dx.doi.org/10.1006/viro.1997.8690.
8. Morrison JA, Raab-Traub N. 2005. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of β-catenin signaling. J. Virol. 79:2375-2382. http://dx.doi.org/10.1128/JVI.79.4.2375-2382.2005.
9. Reth M. 1989. Antigen receptor tail clue. Nature 338:383-384. http://dx.doi.org/10.1038/338383b0.
10. Burkhardt AL, Bolen JB, Kieff E, Longnecker R. 1992. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J. Virol. 66:5161-5167.
11. Fruehling S, Swart R, Dolwick KM, Kremmer E, Longnecker R. 1998. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72:7796-7806.
12. Ikeda M, Ikeda A, Longan LC, Longnecker R. 2000. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domaincontaining ubiquitin-protein ligases. Virology 268:178-191. http://dx.doi.org/10.1006/viro.1999.0166.
13. Winberg G, Matskova L, Chen F, Plant P, Rotin D, Gish G, Ingham R, Ernberg I, Pawson T. 2000. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol. Cell. Biol. 20:8526-8535. http://dx.doi.org/10.1128/MCB.20.22.8526-8535.2000.
14. Chen SY, Lu J, Shih YC, Tsai CH. 2002. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J. Virol. 76:9556-9561. http://dx.doi.org/10.1128/JVI.76.18.9556-9561.2002.
15. Fotheringham JA, Coalson NE, Raab-Traub N. 2012. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk-and Akt-dependent epithelial migration through αV-integrin membrane translocation. J. Virol. 86:10308-10320. http://dx.doi.org/10.1128/JVI.00853-12.
16. Fukuda M, Longnecker R. 2007. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt pathway. J. Virol. 81:9299-9306. http://dx.doi.org/10.1128/JVI.00537-07.
17. Lu J, Lin WH, Chen SY, Longnecker R, Tsai SC, Chen CL, Tsai CH. 2006. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J. Biol. Chem. 281: 8806-8814. http://dx.doi.org/10.1074/jbc.M507305200.
18. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA. 2005. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J. Virol. 79:15430-15442. http://dx.doi.org/10.1128/JVI.79.24.15430-15442.2005.
19. Scholle F, Bendt KM, Raab-Traub N. 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74:10681-10689. http://dx.doi.org/10.1128/JVI.74.22.10681-10689.2000.
20. Freedman VH, Shin SI. 1974. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3:355-359. http://dx.doi.org/10.1016/0092-8674(74)90050-6.
21. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. 1991. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res. 51:381-386.
22. Katz E, Lareef MH, Rassa JC, Grande SM, King LB, Russo J, Ross SR, Monroe JG. 2005. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J. Exp. Med. 201:431-439. http://dx.doi.org/10.1084/jem.20041471.
23. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, Fleckenstein B, Lackner A, Desrosiers RC, Jung JU. 1998. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat. Med. 4:435-440. http://dx.doi.org/10.1038/nm0498-435.
24. Soule HD, Vazguez J, Long A, Albert S, Brennan M. 1973. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1409-1416.
25. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74. http://dx.doi.org/10.1099/0022-1317-36-1-59.
26. Swart R, Ruf IK, Sample J, Longnecker R. 2000. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 74:10838-10845. http://dx.doi.org/10.1128/JVI.74.22.10838-10845.2000.
27. Fukuda M, Longnecker R. 2004. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 78:1697-1705. http://dx.doi.org/10.1128/JVI.78.4.1697-1705.2004.
28. Blume-Jensen P, Hunter T. 2001. Oncogenic kinase signalling. Nature 411:355-365. http://dx.doi.org/10.1038/35077225.
29. Longnecker R, Druker B, Roberts TM, Kieff E. 1991. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65:3681-3692.
30. Scholle F, Longnecker R, Raab-Traub N. 1999. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. J. Virol. 73:4767-4775.
31. Scholle F, Longnecker R, Raab-Traub N. 2001. Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells. Virology 291:208-214. http://dx.doi.org/10.1006/viro.2001.1197.
32. Fruehling S, Lee SK, Herrold R, Frech B, Laux G, Kremmer E, Grasser FA, Longnecker R. 1996. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70: 6216-6226.
33. Matskova LV, Helmstetter C, Ingham RJ, Gish G, Lindholm CK, Ernberg I, Pawson T, Winberg G. 2007. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein. Oncogene 26:4908-4917. http://dx.doi.org/10.1038/sj.onc.1210298.
34. Fukuda M, Longnecker R. 2005. Epstein-Barr virus (EBV) latent mem-brane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J. Virol. 79:8655-8660. http://dx.doi.org/10.1128/JVI.79.13.8655-8660.2005.
35. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161-174. http://dx.doi.org/10.1038/nrc745.
36. Bannish G, Fuentes-Panana EM, Cambier JC, Pear WS, Monroe JG. 2001. Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J. Exp. Med. 194:1583-1596. http://dx.doi.org/10.1084/jem.194.11.1583.
37. Monroe JG. 2006. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat. Rev. Immunol. 6:283-294. http://dx.doi.org/10.1038/nri1808.
38. El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH. 2006. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Res. 66:10553-10559. http://dx.doi.org/10.1158/0008-5472.CAN-06-2333.
39. Cheng S, Coffey G, Zhang XH, Shaknovich R, Song Z, Lu P, Pandey A, Melnick AM, Sinha U, Wang YL. 2011. SYK inhibition and response prediction in diffuse large B-cell lymphoma. Blood 118:6342-6352. http://dx.doi.org/10.1182/blood-2011-02-333773.